99Tcm-MDP全身骨显像在肺癌骨转移诊断中的价值研究

Study on the value of 99Tcm-MDP whole-body bone imaging in the diagnosis of bone metastasis of lung cancer

  • 摘要:
    目的  探讨99Tcm-亚甲基二膦酸盐(MDP)全身骨显像在肺癌骨转移诊断中的价值。
    方法  回顾性分析2019年12月至2022年12月淮南东方医院集团总医院收治的118例肺癌患者的临床资料,其中男性62例、女性56例,年龄(69.5±7.6)岁,范围51~84岁。患者治疗前均行99Tcm-MDP全身骨显像,检查结束后对99Tcm-MDP全身骨显像结果、组织病理学检查结果和随访结果进行分析。通过Kappa检验分析99Tcm-MDP全身骨显像结果与组织病理学检查结果的一致性,评估99Tcm-MDP全身骨显像在肺癌骨转移诊断中的价值。采用χ2检验比较99Tcm-MDP全身骨显像对肺癌不同部位(胸部、中轴、盆腔和四肢)骨转移的诊断灵敏度、特异度、准确率、阳性预测值和阴性预测值。
    结果  118例肺癌患者中,经组织病理学检查结果证实60例(50.85%)存在骨转移,其中颅骨转移2例(3.33%)、胸部骨转移10例(16.67%)、中轴骨转移29例(48.33%)、盆腔骨转移12例(20.00%)、四肢骨转移7例(11.67%);99Tcm-MDP全身骨显像结果显示57例(48.31%)为阳性,其中胸部骨转移10例(17.54%)、中轴骨转移27例(47.37%)、盆腔骨转移11例(19.30%)、四肢骨转移9例(15.79%)。Kappa检验分析结果显示,99Tcm-MDP全身骨显像与组织病理学检查对肺癌骨转移诊断结果的一致性强(Kappa值=0.839,P<0.001),对肺癌不同部位骨转移诊断结果的一致性均较强(Kappa值=0.648~0.732,均P<0.001)。99Tcm-MDP全身骨显像诊断肺癌骨转移的灵敏度、特异度、准确率、阳性预测值、阴性预测值分别为81.67%(49/60)、86.21%(50/58)、83.90%(99/118)、85.96%(49/57)、81.97%(50/61),99Tcm-MDP全身骨显像对肺癌胸部骨转移、中轴骨转移、盆腔骨转移和四肢骨转移的诊断灵敏度、特异度、准确率、阴性预测值的差异均无统计学意义(χ2=1.790~9.136,均P>0.05); 99Tcm-MDP全身骨显像对肺癌胸部骨转移和四肢骨转移的阳性预测值均低于中轴骨转移和盆腔骨转移(均P<0.05)。
    结论  99Tcm-MDP全身骨显像对肺癌骨转移的诊断具有较高的诊断价值,值得临床医师关注。

     

    Abstract:
    Objective  To explore the value of 99Tcm-methylene diphosphate (MDP) whole-body bone imaging in the diagnosis of bone metastasis of lung cancer.
    Methods  Retrospective analysis was conducted on the clinical data of 118 lung cancer patients admitted to General Hospital of Huainan Oriental Hospital Group from December 2019 to December 2022, including 62 males and 56 females, aged (69.5±7.6) years, with a range of 51–84 years old. Before treatment, all patients underwent 99Tcm-MDP whole-body bone imaging. After the examination, the results of 99Tcm-MDP whole-body bone imaging, histopathological examination, and follow-up were subjected to analysis. Kappa analysis was used to analyze the consistency between the results of 99Tcm-MDP whole-body bone imaging and histopathological examination and evaluate the importance of 99Tcm-MDP whole-body bone imaging in the diagnosis of lung cancer bone metastasis. Chi square test was used to compare the sensitivity, specificity, accuracy, and positive and negative predictive values of bone metastasis in different parts of lung cancer (chest bone, axial bone, pelvic bone, and limb bone).
    Results  Among 118 lung cancer patients, 60 cases (50.85%) were confirmed to have bone metastases through histopathological examination. These confirmed cases included 2 cases of skull metastases (3.33%), 10 cases of chest bone metastases (16.67%), 29 cases of axial bone metastases (48.33%), 12 cases of pelvic bone metastases (20.00%), and 7 cases of limb bone metastases (11.67%). The 99Tcm-MDP whole-body bone imaging results reveal that 57 cases (48.31%) were positive for bone metastases, including 10 cases of chest bone metastases (17.54%), 27 cases of axial bone metastases (47.37%), 11 cases of pelvic bone metastases (19.30%), and 9 cases of limb bone metastases (15.79%). Kappa analysis results indicate a strong consistency between 99Tcm-MDP whole-body bone imaging and histopathological examination in the diagnosis of lung cancer bone metastasis (Kappa value=0.839, P<0.001) and in the diagnosis of bone metastasis in various parts of lung cancer (Kappa value=0.648–0.732, all P<0.001). The sensitivity, specificity, accuracy, and positive and negative predictive values of 99Tcm-MDP whole-body bone imaging for the diagnosis of lung cancer bone metastasis were 81.67% (49/60), 86.21% (50/58), 83.90% (99/118), 85.96% (49/57), and 81.97% (50/61), respectively. No significant statistical difference was observed in the sensitivity, specificity, accuracy, and negative predictive value of lung cancer with chest bone, axial bone, pelvic bone, and limb bone metastases (χ2=1.790–9.136, all P>0.05). The positive predictive values of 99Tcm-MDP whole-body bone imaging for chest and limb bone metastases in lung cancer are lower than those of axial and pelvic bone metastases (all P<0.05).
    Conclusion  99Tcm-MDP whole-body bone imaging exhibits a high diagnostic value in the diagnosis of lung cancer bone metastasis, which is worth the attention of clinical physicians.

     

/

返回文章
返回